Roflumilast: a review of its use in the treatment of COPD by Wedzicha JA, Calverley PMA, Rabe KF

Get full text

Influence of body mass on predicted values of static hyperinflation in COPD by Alter P, Rabe KF, Schulz H, Vogelmeier CF, Jörres RA

Get full text

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol by Calverley PM, Martinez FJ, Fabbri LM, Goehring UM, Rabe KF

Get full text

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease by Miravitlles M, Price D, Rabe KF, Schmidt H, Metzdorf N, Celli B

Get full text

Rating sputum cell quality in clinical trials for asthma and COPD treatment by Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O

Get full text

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE S... by Martinez FJ, Rabe KF, Lipworth BJ, Arora S, Jenkins M, Martin UJ, Reisner C

Get full text

Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD by Abdo M, Pedersen F, Trinkmann F, Herth FJF, Rabe KF, Kirsten AM, Watz H

Get full text

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc A... by Bafadhel M, Rabe KF, Martinez FJ, Singh D, Darken P, Jenkins M, Aurivillius M, Patel M, Dorinsky P

Get full text

Identification of novel target genes in human lung tissue involved in chronic obstructive pulmonary disease by Heinbockel L, Marwitz S, Schromm AB, Watz H, Kugler C, Ammerpohl O, Schnepf K, Rabe KF, Droemann D, Goldmann T

Get full text

Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant by Pedersen F, Trinkmann F, Abdo M, Kirsten AM, Rabe KF, Watz H, Baraldo S, Saetta M, Hohlfeld JM, Holz O

Get full text

Persistent Uncontrolled Asthma: Long-Term Impact on Physical Activity and Body Composition by Abdo M, Waschki B, Kirsten AM, Trinkmann F, Biller H, Herzmann C, von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H

Get full text

Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET by Alter P, Stoleriu C, Kahnert K, Henke MO, Bals R, Trudzinski FC, Watz H, Speicher T, Söhler S, Welte T, Rabe KF, Wouters EFM, Vogelmeier CF, Jörres RA

Get full text

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET by Alter P, Kahnert K, Trudzinski FC, Bals R, Watz H, Speicher T, Söhler S, Andreas S, Welte T, Rabe KF, Wouters EFM, Sassmann-Schweda A, Wirtz H, Ficker JH, Vogelmeier CF, Jörres RA

Get full text

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COP... by Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P

Get full text

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgr... by Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C

Get full text

Liberty asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-se... by Busse, WW, Maspero, JF, Rabe, KF, Papi, A, Wenzel, SE, Ford, LB, Pavord, ID, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Akinlade, B, Eckert, L, Chao, J, Graham, NMH, Teper, A

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization by Corren J, Jackson DJ, Casale TB, Borish L, Rabe KF, Busse WW, Maspero JF, Jackson DJ, Daizadeh N, Altincatal A, Radwan A, Khodzhayev A, Djandji M, Jacob-Nara JA, Rowe PJ, Deniz Y

Get full text

Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2 by Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, LeVan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI

Get full text

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis by Maspero, JF, Katelaris, CH, Busse, WW, Castro, M, Corren, J, Chipps, BE, Peters, AT, Pavord, ID, Ford, LB, Sher, L, Rabe, KF, Rice, MS, Rowe, P, Lu, Y, Harel, S, Jagerschmidt, A, Khan, A, Kamat, S, Pirozzi, G, Amin, N, Ruddy, M, Graham, NMH, Mannent, L, Teper, A

A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma by Castro, M, Corren, J, Pavord, ID, Maspero, JF, Wenzel, SE, Rabe, KF, Busse, WW, Ford, LB, Sher, L, Fitzgerald, JM, Katelaris, C, Tohda, Y, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Ruddy, M, Akinlade, B, Khan, A, Chao, J, Martincova, R, Graham, NMH, Teper, A